During the past couple of years, the Rs 72,000- crore Indian pharmaceutical industry has been at the receiving end of a backlash from global and Indian regulators. Apart from damage control to its brand image, the legal expenditure of major Indian ... Business Standard India, 3 days ago
2 images for "sarabjit kour nangra"
Related to : Biocon Ltd,Torrent Pharmaceuticals Ltd,Aurobindo Pharma Ltd Biocon Ltd 388.60 1.25 (0.32%) NSE 05 Dec 13 | 09:29 AM 389.35 1.85 (0.48%) Large-cap pharma companies have been major outperformers over the last few years, ...Smart Investor, 1 week ago Strong pill in medium doses Smart Investor, 6 days ago Angel Broking maintains neutral stance on GSK Pharma MyIris, 3 weeks ago GSK Pharma profit falls 34%, Pfizer net up Financial Chronicle, 1 month ago
posted a third consecutive weekly fall, closing nearly 1 percent lower amid persisting worries over the slowdown in foreign investors buying into Indian shares. Data shows FIIs sold shares worth $9.5 million on Thursday, snapping a 32-day buying ...Reuters India, 2 weeks ago
This is Cipla's second majority stake buy in Africa after it completed acquisition of South Africa's Cipla Medpro in July this year. Cipla, through its wholly-owned subsidiary Meditab Holdings Ltd (MHL), has acquired an additional 14.5 per cent ...VC Circle, 2 weeks ago
The proposed merger between Wyeth and Pfizer in India will lead to re-rating of the merged entity as economies of scale will tilt in its favour. The boards of the two companies, whose parents are already merged following a mega takeover of Wyeth by ...Financial Chronicle, 3 weeks ago
Sun Pharmaceutical Industries, an integrated and speciality pharmaceutical company, today reported a sharp rise of 4.26 times in consolidated net profit to Rs 13.62 billion for the quarter ended Sept. 30, 2013. Consolidated total income for the ...MyIris, 4 weeks ago Issues with USFDA at Caraco facility resolved: Sun Pharma Financial Chronicle, 1 month ago FDA queries addressed, says Sun Pharma Hindu Business Line, 1 month ago
Sanofi has the distinction of being the fastest-growing drug MNC in India for five years, thanks to its MD P B Jayakumar TEXT SIZE : A | A | A TOOLS 1 Shailesh Ayyangar, MD, India, & VP, South Asia global operations, Sanofi RELATED STORIES ...Businessworld India, 4 weeks ago
MUMBAI: Shares of Ranbaxy Laboratories lost 2.80% on Monday after majority shareholder Daiichi Sankyo accused erstwhile owners and of concealing and misrepresenting facts at the time of selling their stake in the company. ET was the first to ...Economic Times, 1 month ago
Source: IRIS (08-NOV-13) Comments | Post Comment We have collated views of analysts on Q2 and Q3 earnings performance and future outlook for key corporates. The same is as follows: Tech Mahindra Ankita Somani, research analyst, Angel ...MyIris, 1 month ago
Indian drugmaker Dr. Reddy's has posted its highest-ever sales and profitability figures not backed by the sales of drug launch in an exclusivity period. The company has posted a growth of 17 per cent in its revenues at Rs 3,357.5 crore in the ...Financial Chronicle, 1 month ago Dr Reddys Q2 profit rises 69% to Rs 690 cr The Financial Chronicle, 1 month ago
on your WebpageAdd Widget >Get your members hooked!